Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of British Columbia
$120,000.00
Deciphering the molecular mechanism of the autophagy factor and Vici syndrome protein EPG5
FY 2025-26
Summary
Our cells comprise a collection of macromolecules and organelles that work together to maintain cellular function and health. As these components age, or in times of stress when the cell needs to conserve energy and metabolites, these components are recycled to meet cellular demands through a process called autophagy. This process begins with the formation of a double-membrane package called the autophagosome which is subsequently delivered to the "cellular incinerator" known as the lysosome where the waste can be recycled. Autophagy can function in two ways: non-selective bulk degradation or targeted selective degradation. When autophagy is impaired, toxic materials accumulate in our cells and can cause diseases including neurodegenerative disorders, cancer, and immunodeficiencies. EPG5 is a protein critical for proper autophagosome-lysosome fusion. Mutations in EPG5 result in a severe disorder called Vici Syndrome that's characterized by neurodegeneration and immunodeficiency. How these mutations affect EPG5 function and lead to the broad symptoms observed in Vici syndrome is not fully understood. Based on recent work from our lab, we hypothesize that EPG5 is involved in not only bulk autophagic degradation, but also in the selective degradation of our cells' energy-producing organelle, the mitochondria, and that defective mitochondrial turnover due to EPG5 malfunction contributes to Vici syndrome. My proposed research aims to understand EPG5's role in the autophagic degradation of mitochondria, identify how EPG5 is recruited to the site of mitochondrial autophagy, and leverage cells from patients with Vici Syndrome to understand the effects of EPG5-related mutations on mitochondrial degradation and its role in Vici syndrome. Altogether, understanding how EPG5 coordinates mitochondrial autophagy will give us a better understanding of the disease mechanisms associated with Vici syndrome and provide insight into potential therapeutics for this devastating disorder.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560004
Name
Shariati Hannah R
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Deciphering the molecular mechanism of the autophagy factor and Vici syndrome protein EPG5
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Autophagy; Endosomal Trafficking; Epg5; Membrane Fusion; Microscopy; Mitophagy; Primary Patient Fibroblast; Proximity-Labelling Mass Spectrometry; Rare Disease
Abstract
Our cells comprise a collection of macromolecules and organelles that work together to maintain cellular function and health. As these components age, or in times of stress when the cell needs to conserve energy and metabolites, these components are recycled to meet cellular demands through a process called autophagy. This process begins with the formation of a double-membrane package called the autophagosome which is subsequently delivered to the "cellular incinerator" known as the lysosome where the waste can be recycled. Autophagy can function in two ways: non-selective bulk degradation or targeted selective degradation. When autophagy is impaired, toxic materials accumulate in our cells and can cause diseases including neurodegenerative disorders, cancer, and immunodeficiencies. EPG5 is a protein critical for proper autophagosome-lysosome fusion. Mutations in EPG5 result in a severe disorder called Vici Syndrome that's characterized by neurodegeneration and immunodeficiency. How these mutations affect EPG5 function and lead to the broad symptoms observed in Vici syndrome is not fully understood. Based on recent work from our lab, we hypothesize that EPG5 is involved in not only bulk autophagic degradation, but also in the selective degradation of our cells' energy-producing organelle, the mitochondria, and that defective mitochondrial turnover due to EPG5 malfunction contributes to Vici syndrome. My proposed research aims to understand EPG5's role in the autophagic degradation of mitochondria, identify how EPG5 is recruited to the site of mitochondrial autophagy, and leverage cells from patients with Vici Syndrome to understand the effects of EPG5-related mutations on mitochondrial degradation and its role in Vici syndrome. Altogether, understanding how EPG5 coordinates mitochondrial autophagy will give us a better understanding of the disease mechanisms associated with Vici syndrome and provide insight into potential therapeutics for this devastating disorder.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shariati, Hannah R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~